Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Where this comes from
- Record sourced from PubMed, PMID 30209272.
- Also identified by DOI 10.1038/s41436-018-0258-3 and PMC identifier 7608211.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The PDF and HTML versions of the article have been updated to include the Creative Commons Attribution 4.0 International License information.